Video

How Renal Function Affects NOAC Dosing

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient's renal function affects appropriate dosing of new oral anticoagulants.

Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how a patient’s renal function affects appropriate dosing of new oral anticoagulants.

This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Muscular dystrophy. A group of diseases that cause progressive weakness and loss of muscle mass. abnormal genes interfere with the production of proteins needed to form healthy muscle - Image credit: Thipphaphone | stock.adobe.com
January 23rd 2025

DYNE-101 Receives FDA Fast Track Designation to Treat Myotonic Dystrophy

Kennedy Ferruggia, Assistant Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Woman experiencing depression -- Image credit: nenetus | stock.adobe.com
January 23rd 2025

Navacaprant Did Not Show Statistically Significant Improvements When Treating Patients With Major Depressive Disorder

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
FDA headquarters -- Image credit: Tada Images | stock.adobe.com
Published: January 23rd 2025 | Updated: January 23rd 2025

FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus

Gillian McGovern, Associate Editor
Doctor or physician recommend pills medical prescription to male Patient hospital and medicine concept - Image credit: joyfotoliakid | stock.adobe.com
January 23rd 2025

Encourage Patient Accountability for Optimal Medication Safety

Kathleen Kenny, PharmD, RPh